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Abstract 
 
Aim: To evaluate the prevalence, characteristics and factors associated with insomnia in 
patients admitted to a palliative care unit. 
Method: Patients consecutively admitted during eight months were surveyed, excluding 
those who presented severe cognitive problems or a too low performance status. The 
survey included the assessment of insomnia using a single question, the assessment of 
moderate to severe insomnia using the Sleep Disturbance Scale (SDS), the evaluation of 
other sleep aspects, the evaluation of physical, psychological and environmental factors 
potentially associated with insomnia, and further clinical and epidemiological data. 
Associations between insomnia and the assessed factors were analysed.  
Main results: Sixty-one patients were included, mean age was 71.5±11 years; 95%  
were oncological patients. Sixty-two percent presented insomnia according to the single 
question and 47% moderate to severe insomnia according to the SDS. Seventy percent 
were moderately worried about insomnia. The most prevalent potentially associated 
factors were pain, clinical psychological distress, nocturnal rumination, and 
environmental factors such as noise or light. Patients claimed physical symptoms to be 
the ones most causing insomnia. In a multivariate analysis, presenting nocturnal 
rumination was associated with more moderate to severe insomnia (OR 5.6 [1.1-29.1] 
p=0.04), and presenting daytime somnolence with less moderate to severe insomnia 
(OR 0.25 [0.07-0.9] p=0.04).  
Conclusions: 1. Insomnia is a prevalent and complex symptom that worries the 
patients. 2. Factors associated with moderate to severe insomnia were nocturnal 
rumination and daytime somnolence (inverse relationship). 2. Detection and 
management of rumination may improve insomnia.  
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Introduction 
 
Insomnia is a prevalent symptom among patients with cancer (Passik et al. 2003; Beck 
et al. 2004), especially in patients with advanced cancer (Mystakidou et al. 2007) and 
patients with advanced oncological disease hospitalised in palliative care units 
(Mercadante et al. 2004).  
 
Data on prevalence of insomnia in patients with advanced cancer in Palliative Care 
Units (PCU) range between 45% and 95%. Instruments used for the evaluation of 
insomnia include the Pittsburg Sleep Quality Index (PSQI) (Mystakidou et al. 2007), 
constructed insomnia questionnaires (Sela et al. 2005), a single item of the Structured 
Clinical Interview for DSM-IIIR (SCID) (Akechi et al. 2007), among others.  
 
Several clinical, demographical and biological factors have shown to be associated with 
the presence of insomnia. Emotional disturbances seem to be associated with insomnia 
in persons with advanced oncological disease, (Anderson et al. 2003; Davidson JR et al. 
2002), as well as physical symptoms like pain (Davidson JR et al. 2002; Mystakidou et 
al. 2007), age (inverse relationship), and certain pharmacological treatments (Davidson 
JR et al. 2002). Empirical evidence  suggests that biological factors such as citoquines 
can contribute to the disruption of the sleep cicle (Kvale et al. 2006). In PCUs, 
environmental factors such as light or noise could also influence the sleep quality of the 
patients admitted.   
 
Insomnia brings patients discomfort and suffering, and has physical and psychological 
consequences such as increase of pain intolerance, irritability and depressive mood 
(Beck et al. 2004).  
 
Insomnia is often underreported by patients (Engstrom CA et al. 1999). Its routine 
clinical assessment is often suboptimal. The use of a standard instrument to evaluate 
insomnia could facilitate its detection (Kvale et al. 2006). 
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Patients are normally admitted in PCUs for relatively short time periods, often not more 
than two weeks. Disturbing symptoms presented by the patients are daily evaluated by 
professionals in PCU, as their intensity and characteristics can change from one day to 
the next. Some of the existing instruments for the evaluation of sleep disturbances refer 
to the preciding 15 days or four weeks, and are relatively long to respond, making their 
day-to-day use unfeasible. 
 
The main purpose of the present study is to study the prevalence of insomnia among the 
patients admitted to a PCU using a single question and the questionnaire Sleep 
Disturbance Scale, and to analyse the factors associated with the presence of insomnia. 
Secondary objectives are to describe the characteristics of insomnia in these patients and 
the prevalence of other factors potentially associated with insomnia, including 
emotional disturbances, physical symptoms and environmental factors.  
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Methods  
 
Study population 
 
Participants were patients consecutively admitted to the PCU at the Hospital de 
l’Esperança in Barcelona during an eight months period. Data inclusion finished in 
October 2009. Inclusion criteria were: appropriate performance status enabling 
participation (Karnofsky Index ≥30), cognitive status enabling understanding of the 
questionnaire administered (Pfeiffer Index ≤4 errors), and hospital stay for ≥3 days. The 
first two nights of admission were excluded, in order to avoid an overestimation of 
insomnia due to change of place and patients’ emotional overwhelm.  
 
Procedures 
 
A Case Report Form (CRF) was developed after a literature review. Approval of the 
study protocol and the CRF was obtained by the Ethical Comittee for Clinical Research 
of the Hospital Parc de Salut Mar in Barcelona. CRFs were administered by three 
trained nursing staff employed at the PCU. The training consisted of one session 
imparted by a researcher (AR) or one experienced nurse, and aimed to teach how to 
administer the CRF in a standarized way. Patients’ oral informed consent was obtained. 
Demographic data were extracted from patients’ records.   
 
Measures (see Annex 2) 
 
Assessment of insomnia 
Insomnia was evaluated using two instruments: 
1. Insomnia single question. Patients were asked “Have you been suffering from 
insomnia since you have been admitted?”. Possible answers were “yes”, “no” or 
“sometimes”.  Patients were classified into: “insomnia according to the single question” 
(answer yes) or “no insomnia according to the single question” (answer no or 
sometimes). Although this is a non-validated question, it was considered of interest for 
being a common question in the day-to-day practice.  
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2. Sleep questionnaire. The Sleep Disturbance Scale (SDS), developed in the context of 
the study by Anderson et al. (2003), was chosen because it is short and refers to the 
previous 24 hours. The SDS assesses three main sleep items: difficulty in falling asleep, 
waking up during the night and waking up too early in the morning. Patients are asked 
to score each item at a Likert scale from 0 to 10. An overall sleep disturbance score is 
calculated as the average of the rated scores of the three sleep items. Patients are 
classified into those with moderate to severe insomnia (overall sleep disturbance score 
≥5) and those without moderate to severe insomnia (overall sleep disturbance score <5). 
In the study by Anderson et al. (2003), the SDS demonstrated adequate internal 
reliability, with a coefficient alpha of 0.71. Construct validity was supported by factor 
analysis and a single underlying construct was identified. The scale includes a last 
independent item asking patients to judge the total number of hours they sleep per night. 
Patients are classified in those who report sleeping <5 hours and those who report 
sleeping ≥5 hours per night. For the present study, the scale was translated to Catalan by 
one of the researchers (AR) and the time reference was widened to “since you have 
been admitted”.  
 
Other questions in relation to insomnia 
Patients were asked to rate how worried about insomnia they were, using a Likert scale 
from 0 to 5. A score of >3 was considered as moderate. Patients where further asked if 
they suffered from daytime somnolence, feeling of non-restorative sleep, and when 
insomnia had started (before diagnosis of the current disease, after diagnosis or after 
admission to the PCU).  
 
Assessment of Physical Factors  
Physical symptoms potentially associated with insomnia were assessed asking patients 
whether the following symptoms interferred with their sleep quality: dyspnea, 
functional incontinence, fever, sweating, nausea or vomiting, itch, pain, drug or tobacco 
abstinence, nycturia, cough, restless-legs.  
 
Assessment of Psychological Factors 
Emotional distress was measured by the Hospital Anxiety and Depression Scale 
(HADS), a validated 14-items scale which has been used in patients with advanced 
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oncological disease (Zigmond and Snaith, 1983; Spanish validation by Herrero et al. 
2003). Clinically significant emotional distress was considered at a HADS score of  
>19. This scale includes two subscales, separately evaluating clinical anxiety and 
depression. A score of  >11 for each subscale indicates anxiety or depressed mood, 
respectively. The cut off scores have also been used in other studies on emotional 
distress among cancer patients (Grassi et al. 2004). Other psychological aspects 
evaluated were presence of nightmares, feeling of fear or loneliness and presence of 
nocturnal rumination, defined as nighttime preoccupation with thoughts about past or 
present occurrences. The degree of information about the diagnosis and prognosis of the 
present disease was rated by the interviewer according to his/her impression after the 
interview. 
 
Assessment of Environmental Factors  
Patients were asked if light or noise coming from the own shared room or from the 
ward, as well as nurse interruptions were interfering with the quality of their sleep. 
Information whether the patient slept in an individual room and whether the family 
accompanied him/her during the night was collected. Patients were asked if they had 
sleep habits at home that could not be accomplished at the PCU. 
 
Judged main factor interfering with sleep quality 
Patients were asked at the end of the interview which of the following factors were 
interfering the most with the quality of their sleep: physical, psychological or 
environmental factors. 
 
Other variables  
Sociodemografic data, place of procedence (home or acute care), death during PCU 
stay, clinical information on the diagnosis and stage of the disease, comorbidity and 
medication were collected from the patients’ records.  
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Statistical Analysis 
 
A sample size of 60 patients was calculated, assuming that the prevalence of insomnia 
and emotional distress would be comparable to the prevalence in similar samples of 
patients, and considering a potential association between insomnia and emotional 
distress. 
 
All statistical analysis were performed using SPSS 15.0 package (SPSS Inc., Chicago, 
IL). Means, standard deviations and ranges were calculated for the measured scale 
variables. Basic descriptive statistics were computed for the sociosociodemographic 
variables, insomnia additional items and factors potentially associated with insomnia.  
 
An univariate analysis was performed in order to investigate associations between 
insomnia and the potentially associated factors. Mann-Whitney Test, Chi-square and 
Fischer’s Exact Test were used, depending on the type of the scale and the distribution 
of the categories. A multivariate regression analysis was performed in order to 
investigate associations between the factors and presence of moderate to severe 
insomnia. Secondary analysis were performed in order to better understand associations 
between the different data analysed.  
 
 
 
 
 
 
 
 
 
 
Insomnia in hospitalised patients with advanced disease 
Renom Guiteras A  
  
 
 10
Results (see Tables in Annex 1) 
 
One hundred seventy-seven patients were consecutively admitted to the PCU during the 
eight-month period. Sixty-one patients (34%) fulfilled the inclusion criteria. Ninety-one 
patients (51%) did not fulfill the inclusion criteria, either because they were cognitively 
too impaired, had a Karnofsky Index <30, or spent less than three days at the PCU. 
Twenty-three admitted patients (13%) were not assessed for inclusion due to because of 
organizational reasons and two did not give their informed consent.  
 
Descriptive data 
 
Characteristics of the sample  
Thirty-four men and 27 women were included, mean age was 71.5 ± 11 years. The 
majority of included patients suffered from cancer (95.1%), with a high prevalence of 
metastasic cancer (68.9%). Sixty percent were sent to the PCU from an acute care unit 
and 40% from home care. Table 1 (Annex 1) displays the socio-demographic and 
clinical characteristics of the included patients.  
 
Prevalence and characteristics of insomnia 
Thirty-eight patients (62.3%) presented insomnia according to the single question. 
Twenty-nine patients (47.5%) presented moderate to severe insomnia according to the 
SDS. The sleep item of the SDS that scored the highest was “waking up during the 
night”. Sixty-two percent of the patients rated this item with >5. The sleep item 
“difficulty in falling asleep” was the second higher scored, followed by “waking up too 
early in the morning”. Twenty-one patients (34.4%) reported <5 hours sleep per night. 
Table 2 (Annex 1) shows the results on insomnia prevalence.  
 
Insomnia often started together with the current disease, and less frequently since 
admission to the PCU. Seventy percent of the patients were moderately worried about 
insomnia. Feeling of nonrestorative sleep and daytime somnolence were frequent. Table 
3 (Annex 1) shows descriptive data on this aspects. 
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Prevalence of potentially associated factors 
Table 4 (Annex 1) shows the prevalence of the studied factors potentially associated 
with insomnia. 
Physical factors. Pain was the most frequently claimed symptom interfering with sleep 
quality (68.9%), followed by dyspnea and cough.  
Psychological factors. The prevalence of clinically significant emotional distress was 
high (63.9%). Nocturnal rumination, nightmares and feelings of fear or loneliness were 
prevalent. Thirty-nine patients were judged by the interviewers as being aware of the 
present diagnosis, while twelve were judged as being aware of the prognosis.  
Environmental factors. Forty-seven patients (77%) reported at least one environmental 
factor interfering with the quality of their sleep.  
 
Judged main factor interfering with sleep quality 
When asked which group of factors was most interfering with sleep quality, most 
patients (68.9%) mentioned the physical group, being environmental and psychological 
factors less mentioned (Figure 1, Annex 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Insomnia in hospitalised patients with advanced disease 
Renom Guiteras A  
  
 
 12
Univariate and multivariate regression analysis 
 
Factors associated with insomnia according to the single question 
Table 5. (Annex 1) displays the results of the univariate analysis. Insomnia according to 
the single question was significantly associated with having a feeling of non-restorative 
sleep, reporting <5 hours sleep per night, presenting moderate to severe insomnia 
according to the SDS, being moderately worried about insomnia, mentioning dispnea as 
a symptom interfering with sleep quality, suffering from nocturnal rumination, having a 
higher score in HADS, and suffering from clinical anxiety. Patients with insomnia were 
more often judged as being clearly aware of the current diagnosis, and had a higher 
Karnofky Index.  
A marginally significant association between lung cancer and insomnia according to the 
single question was found, in comparison to the group “other cancer sites”.  
 
Factors associated with insomnia according to the SDS 
Table 6. (Annex 1) displays the results of the univariate analysis. Moderate to severe 
insomnia was significantly associated with the variables insomnia according to the 
single question, being moderately worried about insomnia, the Karnofsky Index, 
nocturnal rumination, daytime somnolence and presence of environmental  
disturbances. Neither any of the physical factors nor the presence of clinically 
significant emotional distress were found to be associated with the presence of moderate 
to sever insomnia.  
 
The multivariate regression analysis showed that presenting nocturnal rumination was 
associated with more moderate to severe insomnia (OR 5.6 (1.1-29.1); p=0.041), and 
presenting daytime somnolence with less moderate to severe insomnia (OR 0.25 (0.07-
0.9); p=0.043).  
 
Secondary analysis 
A secondary analysis investigating the relationship between clinically significant 
emotional distress and other sleep aspects revealed that emotional distress was 
associated with being more worried about insomnia (Table 7, Annex 1). 
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Possible association between rumination and psychological distress was analysed. 
Patients with nocturnal rumination presented significantly more clinical anxiety 
according to the HADS subscale anxiety (Table 8, Annex 1).  
Possible association between nocturnal rumination and each of the sleep items was 
analysed. Rumination was significantly associated with difficulties in sleep 
maintainance and early waking up, while not associated with difficulties in falling 
asleep (Table 9, Annex 1).  
Factors potentially associated with daytime somnolence were studied. Daytime 
somnolence was associated with receiving psychotropic medication (neuroleptics and 
benzodiazepines excluded), and marginally associated with receiving benzodiazepines 
(Table 10, Annex 1). 
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Discussion 
 
The present study aimed to study two aspects related to insomnia in PCUs: prevalence 
and the factors associated.  
 
Sixty-two percent of the patients answered “yes” to the single question “Have you been 
suffering from insomnia since your admission?”, and 47% presented moderate to severe 
insomnia according to the Sleep Disturbance Scale (SDS). The most affected sleep item 
was sleep maintainance, followed by difficulties in falling asleep and early waking. 
Thirty-four percent of the patients reported <5 hours sleep per night. The study showed 
that patients worry about insomnia, suggesting that insomnia is not only prevalent but 
also a troublesome symptom.  
 
Two symptoms were found associated with moderate to severe insomnia in the 
multivariate regression analysis: the presence of nocturnal rumination and the presence 
of daytime somnolence (inverse relationship). In a secondary analysis, nocturnal 
rumination was associated with anxiety, more difficulties in sleep maintainance and 
more early waking. Daytime somnolence was associated with the intake of psychotropic 
medication.  
 
Analysis of the prevalence of potentially associated factors and univariate analysis using 
the two instruments showed interesting results.  
 
Patients reported the group of physical factors as most often interfering with the quality 
of their sleep. The most prevalent physical factor interfering with sleep quality was 
pain. However, it was not associated with insomnia neither measured with the single 
question nor with the SDS. Dyspnea interfering with sleep quality was also relatively 
prevalent and associated with insomnia according to the single question.  
 
Environmental disturbances such as noise coming from the own room or the ward and 
nurse interruptions were often mentioned as interfering with the quality of sleep of the 
patients.  
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Clinically significant emotional distress and anxiety were prevalent and and associated 
with insomnia when measured with the single question. Clinically significant emotional 
distress was associated with being more worried abour insomnia, and with the presence 
of nocturnal rumination, but not associated with moderate to severe insomnia according 
to the SDS. 
 
No significant associations between insomnia and other demographical or clinical 
variables were found, except on a statistical tendency towards younger patients 
presenting more insomnia according to the single question. A better performance status 
measured by Karnofsky Index was found to be associated with a major prevalence of 
moderate to severe insomnia. This result was not confirmed in the multivariate analysis.  
 
The single non-validated question on insomnia “Have you been suffering from insomnia 
since your admission?” might be a sensitive method for detecting insomnia but could 
also tend to select the subsample of patients with emotional distress, since patients who 
complain of poor sleep are generally more anxious (Gibbins et al. 2009). 
 
The SDS might be a specific instrument for the detection of insomnia, since it assesses 
moderate to severe insomnia. It is easy and quick to administrate, refers to a short 
previous time period, and gives information on the three sleep items: falling asleep, 
waking up during the night and early waking. The SDS might be adequate for the 
assessment of insomnia in PCUs.  
 
Data on prevalence of the present study is similar to prevalence data from other studies. 
Studies using the Pittsburg Sleep Quality Index (PSQI) found prevalences of 73% or 
96% of “poor sleepers” using different cut off scores (Mystakidou et al. 2007; 2009). 
Prevalence of insomnia measured by a constructed questionnaires was 72% (Sela et al. 
200%) and 44.5% measured using one item of the major depressive episode jmodule of 
the Structured Clinical Interview for DSM-IIIR (SCID) (Akechi et al. 2007). One study 
found a prevalence of 70% by asking a single question  “Do you have trouble sleeping 
at night?” (Hugel et al. (2004)). 
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The fact that the most affected sleep item was “waking up during the night” coincides 
with data from other studies (Davidson et al. 2002, Sela et al. 2005). In PCU, the most 
affected sleep item might differ from other groups of patients. A detailed assessment of 
each sleep item might be helpful.  
 
The number of hours slept per night reported by the patients has been used as a method 
for detecting insomnia and thought to be of interest, as 5 hours are considered the 
minimal time needed to provide sleep efficiency (Mercandante et al. 2004). Other 
studies have reported similar results on the percentage of patients sleeping ≤5 hours per 
night (Mercandante et al. 2004). 
 
Studies on factors associated with insomnia show different results. The most often cited 
factors associated with insomnia are pain and psychological symptoms. 
 
Uncontrolled pain, pain treatment and "interference of pain with mood" seam to 
influence insomnia (Mistakidou et al. 2007; Hugel et al. 2004). Pain should be taken 
into special consideration when assessing and managing insomnia, since patients often 
attribute insomnia to it (Davidson et al 2002; Mystakidou et al. 2007).  
 
Improvement of environmental factors such as noise, light or night interruptions should 
also be considered, since most patients state that these factors interfer with their sleep.   
 
Treating emotional distress seams important for the general management of insomnia. 
Different psychological factors seam to be associated with insomnia: low or variable 
mood, dreams, concerns, hopelessness, post-traumatic experience, anxiety, depression 
(Davidson et al. 2002; Mistakidou et al. 2007; Mercandante et al. 2004; Gibbins 2009). 
More specifically, anxiety has been studied in relation to insomnia and found associated 
with difficulties in falling asleep, less restoring sleep and nightmares. Depression has 
been associated with early awaking, nonrestorative sleep, fatigue, nightmares and 
insomnia according to the PSQI (Mercandante et al. 2004; Mystakidou et al. 2009). In 
the present study emotional distress was associated with insomnia only when measured 
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with the single question, with being moderately worried about insomnia, and with 
nocturnal rumination.  
 
The present study defined rumination as “nighttime preoccupation with thoughts about 
past or present occurrences”. Rumination, “things mulling over in the head”, thoughts 
and concerns seem to be associated with insomnia (Hugel et al. 2004, Davidson et al 
2002). Rumination is involved in increased psychological distress in palliative care 
(Galfin et al. 2011). In the present study, rumination but not clinical anxiety or 
emotional distress was associated with moderate to severe insomnia. This results 
suggest that, although many patients in PCUs present psychological distress, only the 
specific symptom rumination might be associated with moderate to severe insomnia. 
Detecting nocturnal rumination and addressing it by providing adequate support could 
improve insomnia. An adequate psychological and social support during admission and 
also in earlier phases of the disease might be a promising approach. 
 
Daytime somnolence has been considered as a type of sleep disturbance (Davidson et al. 
2002). Pharmacological treatment and biological aspects associated with advanced 
cancer such as cytokines influencing the sleep-wake cycle (Dunlop et al. 2000) could 
influence the presence of daytime somnolence. Data on the relationship between 
daytime somnolence and insomnia in patients admitted to PCUs is scarce. Results of the 
present study suggest that patients with daytime somnolence might not suffer from 
moderate to severe insomnia, while patients with moderate to severe insomnia might be 
awake during daytime. This information could be of interest when assessing sleep 
disturbance in patients admitted to a PCU. Further studies are needed in order to 
understand the relationship between daytime somnolence and insomnia, and to 
investigate the presence of other factors involved.  
 
Age has been found inversely related to insomnia prevalence (Davidson et al. 2002). 
The present study found a non-significant association in the same direction. Fatigue, leg 
restlessness, the use of sedative/hypnotic drugs, recent cancer surgery (Davidson et al. 
2002; Mercandante et al. 2004), quality of life, opioids (Mistakidou et al. 2007) could 
also influence insomnia. The present study does not confirm this results.  Fatigue, recent 
cancer surgery and quality of life have not been assessed in the present study.  
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The fact that patients attributed insomnia mostly to physical symptoms has been 
described in other studies (Hugel et al. 2004). Patients might underrecognise or 
underreport psychological symptoms such as ruminations, which might partially explain 
why the answer given by the patients differ from the results of the multivariate analysis.  
 
Clusters of symptoms in palliative care are currently being investigated, as they could 
share underlying mechanisms and be therefore managed as a whole. Insomnia has been 
categorised in different cluster groups by different authors. Tsai JS et al. (2010) 
suggested insomnia to be part of the "autonomic dysfunction" cluster; Jiménez et al. 
(2011) categorised insomnia as part of the neuropsychological cluster; Cleeland et al. 
(2002) identified sleep disturbance as relatively independent of other symptoms. 
Although the aim of the present study was not to investigate to which cluster of 
symptoms insomnia could belong, results do not clearly support any of the suggested 
categorisations of the symptom insomnia.  
 
More prospective studies are needed which might help to elucidate the most important 
aspects to treat and modify in order to improve the sleep quality of patients at PCUs. A 
comprehensive assessment of the symptom and its potentially associated factors with 
special attention to rumination and daytime somnolence is required, since insomnia is a 
disturbing and worrying symptom in patients with advanced disease.  
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Study limitations 
 
The present study has limitations. The translation of the SDS was performed by a 
researcher who was not bilingual and recommendations including forward backward 
translation were not fulfilled.  However, the items included in the scale are not complex 
in terms of language and no important cultural differences after translation are expected. 
The time reference used by Anderson et al. (2004) for the scale SDS was modifyed for 
the present study.  
 
Assessors administering the CRFs were nursing staff employed at the PCU. Therefore, 
they were not independent. 
 
Interpretation of the results of certain variables could be limited by the sample size.  
 
Only few of the consecutively admitted patients fulfilled the inclusion criteria. Half of 
the patients were too confused or had a too bad general status. Other studies have found 
similar experiences when including patients for the evaluation of insomnia (Aketchi et 
al. 2007). Excluded patients might have suffered from insomnia but could not be 
evaluated through the questionnaire. Included patients had a better cognitive status and 
relatively good performance status. This fact should be taken into account when 
interpreting and eventually generalizing the results of the present study.    
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Conclusions 
 
1. Insomnia is a prevalent symptom that worries patients admitted to PCUs.  
2. Emotional distress is highly prevalent among patients in PCU, but is not associated 
with moderate to severe insomnia.  
3. The psychological symptom nocturnal rumination was associated with the presence 
of moderate to severe insomnia.  
4. The presence of daytime somnolence was associated with less moderate to severe 
insomnia, which could be a clinical aspect to consider. 
More prospective studies are needed in order to know why and by means of which 
mechanisms patients admitted to PCUs present insomnia. The homogeneous use of 
specific tools for the assessment of insomnia in PCUs should be promoted. 
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Annex 1 
 
Table legends 
 
 Table 1: Patients’ socio-demographic and clinical characteristics  
 Table 2: Insomnia prevalence 
 Table 3: Other aspects related to insomnia and sleep quality 
 Table 4: Prevalence of factors potentially associated with insomnia 
 Table 5: Relationship between the studied variables and insomnia 
according to the single question in the sample  
 Table 6: Relationship between the studied variables and moderate to sever 
insomnia according to the Sleep Disturbance Scale 
 Table 7: Relationship between clinically significant emotional distress and 
other sleep aspects 
 Table 8: Relationship between rumination and other psychological factors  
 Table 9: Relationship between rumination and insomnia items  
 Table 10: Relationship between the sociodemographical and clinical 
characteristics and daytime somnolence  
 Figure 1: Judged main factor interfering with sleep quality 
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Table 1. Patients’ socio-demographic and clinical characteristics (n=61) 
 n (%) 
Sex (man) 34 (55.7) 
Mean age ± SD, years 71.5 ± 11  
Mean Pfeiffer Index ± SD* 1.28 ± 1.082 
Mean Karnofsky Index ± SD† 47.7 ± 11  
Main diagnosis 
Oncological 58 (95.1) 
Non-oncological 3 (4.9) 
Cancer site 
Lung 13 (21.3) 
Colon 10 (16,4) 
Gynaecological (not breast) 7 (11.5) 
Urinary tract 6 (9.8) 
Breast 4 (6.6) 
Liver 3 (4.9) 
Stomach 4 (6.6) 
Other 9 (14.7) 
Unknown 2 (3.3) 
Not applicable (non-oncological patient) 3 (4.9) 
Stage 
Local or loco-regional disease 16 (26.2) 
Metastasic 42 (68.9) 
Not applicable (non-oncological patient) 3 (4.9) 
Procedence 
Home 24 (39.3) 
Acute Care 37 (60.7) 
Death during hospitalisation in the PCU 28 (45.9) 
Medication intake 
Neuroleptics (also if used for nausea or vomiting) 24 (39.3) 
Sympathicomimetica 18 (29.5) 
Corticosteroids 34 (55.7) 
Diuretics 21 (34.4) 
Opioids 44 (72.1) 
Psyhotropics (neuroleptics/benzodiazepines excluded) 23 (37.7) 
Antihistaminic 1 (1.6) 
Benzodiazepines 38 (62.3) 
* Pfeiffer Index range: 0-10; † Karnofsky Index range: 0-100
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Table 2. Insomnia prevalence (n=61) 
Single question on insomnia 
Have you been suffering from insomnia since your 
admission? 
Yes  
n (%) 
No 
n (%) 
 38 (62.3) 23 (37.7) 
Sleep Disturbance Scale (moderate to severe insomnia) 
During the time you have been hospitalised have 
you suffered from ...? 
≥5  
n (%)  
<5  
n (%) 
Difficulty in falling asleep (Likert 0-10) 33 (54.1) 28 (45.9) 
Waking up during the night (Likert 0-10) 38 (62.3) 23 (37.7) 
Waking up too early in the morning (Likert 0-10) 31 (50.8) 30 (49.2) 
Sleep disturbance score 29 (47.5) 32 (52.5) 
Reported hours sleep per night <5 
n (%) 
≥5 
n (%) 
 21 (34.4) 40 (65.6) 
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Table 3. Other aspects related to insomnia and sleep quality (n=61) 
 n (%) 
Start point of sleep difficulties  
Before the current disease 18 (29.5) 
Together with the current disease 27 (44.3) 
Since admission to the PCU 7 (11.5) 
Non applicable (the patient did not claim to have insomnia) 9 (14.7) 
Being moderately worried about insomnia   
Yes (≥3) (Likert 0-5) 43 (70.5) 
No (<3) (Likert 0-5) 18 (29.5) 
Feeling of non-restorative sleep 32 (52.5) 
Daytime somnolence 45 (73.8) 
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Table 4. Prevalence of factors potentially associated with insomnia (n=61) 
 n (%) 
Physical symptoms claimed to be interfering with sleep quality  
Pain 42 (68.9) 
Dyspnea 22 (36.1) 
Cough 18 (29.5) 
Nausea, vomiting 15 (24.6) 
Sweating 13 (21.3) 
Nycturia 11 (18.0) 
Functional incontinence 8 (13.1) 
Itch 7 (11.5) 
Restless-legs 5 (8.2) 
Fever  1(1.6) 
Drug or tobacco abstinence 5 (8.2) 
Psychological symptoms 
Mean HADS score ± SD * 21.6 ± 7.7  
Clinically significant emotional distress (HADS score ≥ 19) 39 (63.9) 
Clinical depression (HADD ≥11) 38 (62.3) 
Clinical anxiety (HADA ≥11) 33 (54.1) 
Nightmares 16 (26.2) 
Rumination 48 (78.7) 
Fealings of fear or loneliness 30 (49.2) 
Clear knowledge on the current disease’s diagnosis 39 (63.9) 
Clear knowledge on the current disease’s prognosis 12 (19.7) 
Environmental factors 
Reported environmental factor influencing sleep quality 47 (77) 
Individual room 28 (29.5) 
Accompanied by a next of kin during night 15 (24.6) 
Sleep habits not accomplished at the PCU 19 (31.1) 
 
* Hospital Anxiety and Depression Scale; range 0-42
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* Statistical analysis excluded the 3d group 
 
Table 5. Relationship between the studied variables and insomnia according to the single 
question in the sample (n=61) 
Variables Insomnia according to the single question P-value 
 n (%) n (%)  
 No Yes  
 23 (37.7) 38 (62.3)  
Socio-demographic and clinical characteristics    
Mean age ± SD, years 74.3 ± 9.73  69.8 ± 11.49 0.072 
Sex   0.33 
Women 12 (44.4) 15 (55.6)  
Men 11 (32.4) 23 (67.6)  
Karnofsky index    0.003 
>50 1 (6.3) 15 (93.8)  
≤50 22 (48.9) 23 (51.1)  
Procedence (home vs acute care)   0.11 
Home 12 (50) 12 (50)  
Acute Care 11 (29.7) 26 (70.3)  
Death during hospitalisation in the PCU   0.768 
No 13 (39.4) 20 (60.6)  
Yes 10 (35.7) 18 (64.3)  
Cancer site    0.056* 
Lung 2 (15.4) 11 (84.6)  
Other 21 (46.6) 24 (53.3)  
Non-applicable (non-oncological patient) 0 (0) 3 (100)  
Stage    0.239* 
Local or loco-regional disease 9 (56.3) 8 (43.8)  
Metastasic 14 (33.3) 28 (66.7)  
Non-applicable (non-oncological patient) 0 (0) 3 (100)  
Intake of neuroleptics    0.111 
No 11 (29.7) 26 (70.3)  
Yes 12 (50) 12 (50)  
Intake of sympathicomimetica   0.301 
No 18 (41.9) 25 (58.1)  
Yes 5 (27.8) 13 (72.2)  
Intake of corticosteroids   0.333 
No 12 (44.4) 15 (55.6)  
Yes 11 (32.4) 23 (67.6)  
Intake of diuretics   0.547 
No 14 (35) 26 (65)  
Yes 9 (42.9) 12 (57.1)  
Intake of opioids   0.728 
No 7 (41.2) 10 (58.8)  
Yes 16 (36.4) 28 (63.6)  
Intake of psyhotropics    0.145 
No 17 (44.7) 21 (55.3)  
Yes 6 (26.1) 17 (73.9)  
Intake of benzodiazepines   0.728 
No 8 (34.8) 15 (65.2)  
Yes 15 (39.5) 23 (60.5)  
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Table 5 (continued). Relationship between the studied variables and insomnia according to the 
single question in the sample (n=61) 
Variables Insomnia according to the single question P-value 
 n (%) n (%)  
 No Yes  
 23 (37.7) 38 (62.3)  
Other sleep factors    
Moderate to severe insomnia according to the SDS    0.020 
No 18 (56.3) 14 (43.8)  
Yes 5 (17.2) 24 (82.8)  
Being moderately worried about insomnia   0.003 
No 12 (66.7) 6 (33.3)  
Yes 11 (25.6) 32 (74.4)  
Reported hours sleep per night   0.029 
<5 4 (19) 17 (81)  
≥5 19 (47.5) 21 (52.5)  
Feeling of non-restorative sleep    0.007 
No 16 (55.2) 13 (44.8)  
Yes 7 (21.9) 25 (78.1)  
Daytime somnolence    0.237 
No 8 (50) 8 (50)  
Yes 15 (33.3) 30 (66.7)  
Physical factors    
Pain   0.633 
No 8 (42.1) 11 (57.9)  
Yes 15 (35.7) 27 (64.3)  
Dyspnea   0.018 
No 19 (48.7) 20 (51.3)  
Yes 4 (18.2) 18 (81.8)  
Cough    0.649 
No 17 (39.5) 26 (60.5)  
Yes 6 (33.3) 12 (66.7)  
Nausea, vomiting    0.150 
No 15 (32.6) 31 (67.4)  
Yes 8 (53.3) 7 (46.7)  
Sweating    0.530 
No 17 (35.4) 31 (64.6)  
Yes 6 (46.2) 7 (53.8)  
Nycturia    1.000 
No 19 (38) 31 (62)  
Yes 4 (36) 7 (63.6)  
Functional incontinence    0.461 
No 19 (35.8) 34 (64.2)  
Yes 4 (50) 4 (50)  
Itch    1.000 
No 20 (37) 34 (63)  
Yes 3 (42.9) 4 (57.1)  
Restless-legs   1.000 
No 21 (37.5) 35 (62.5)  
Yes 2 (40) 3 (60)  
Fever     1.000 
No 23 (38.3) 37 (61.7)  
Yes 0 (0) 1 (100)  
Drug or tobacco abstinence   1.000 
No 22 (37.9) 36 (62.1)  
Yes 1 (33.3) 2 (66.7)  
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Table 5 (continued). Relationship between the studied variables and insomnia according to the 
single question in the sample (n=61) 
Variables Insomnia according to the single 
question 
P-value 
 n (%) n (%)  
 No Yes  
 23 (37.7) 38 (62.3)  
Psychological factors    
HADS score 18.17±7.64 23.66±6.98 0.012 
Clinically significant emotional distress  (HADS≥19)   0.137 
No 11 (50) 11 (50)  
Yes 12 (30.8) 27 (69.2)  
Subscala depression (HADD)   0.204 
HADD<11 11 (47.8) 12 (52.2)  
HADD≥11 12 (31.6) 26 (68.4)  
Subscala anxiety (HADA)    0.019 
HADA<11 15 (53.6) 13 (46.4)  
HADA≥11 8 (24.2) 25 (75.7)  
Nightmares    0.535 
No 18 (40) 27 (60)  
Yes 5 (31.3) 11 (68.8)  
Rumination   0.012 
No 9 (69.2) 4 (30.8)  
Yes 14 (29.2) 34 (70.8)  
Fealings of fear or loneliness    0.222 
No 14 (45.2) 17 (54.8)  
Yes 9 (30) 21 (70)  
Clear knowledge on the current diagnosis    0.042 
No 12 (54.5) 10 (45.5)  
Yes 11 (28.2) 28 (71.8)  
Clear knowledge on the current prognosis    0.751 
No 18 (36.7) 31 (63.3)  
Yes 5 (41.7) 7 (58.3)  
Environmental factors    
Environmental disturbances (noise, light)   0.650 
No 6 (42.9) 8 (57.1)  
Yes 17 (36.2) 30 (63.8)  
Individual room    0.301 
No 18 (41.9) 25 (58.1)  
Yes 5 (27.8) 13 (72.2)  
Accompanied by a next of kin during night   0.310 
No 19 (41.3) 27 (58.7)  
Yes 4 (26.7) 11 (73.3)  
Sleep habits not accomplished at the PCU   0.217 
No 18 (42.9) 24 (57.1)  
Yes 5 (26.3) 14 (73.7)  
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* Statistical analysis excluded the 3d group 
 
 
Table 6. Relationship between the studied variables and moderate to severe insomnia according 
to the Sleep Disturbance Scale (n=61) 
Variables Moderate to severe insomnia  P-value 
 n (%) n (%)  
 No Yes  
 32 (52.5) 29 (47.5)  
Sociodemographical and clinical characteristics    
Age  73.19±9.95 69.64±11.96 0.289 
Sex   0.102 
Women 11 (40.7) 16 (59.3)  
Men 21 (61.8) 13 (38.2)  
Karnofsky index    0.048 
>50 27 (60) 18 (40)  
≤50 5 (31.3) 11 (68.8)  
Procedence (home vs acute care)   0.060 
Home 9 (37.5) 15 (62.5)  
Acute Care 23 (62.2) 14 (37.8)  
Death during hospitalisation in the PCU   0.088 
No 18 (64.3) 10 (35.7)  
Yes 14 (42.4) 19 (57.6)  
Cancer site   0.534* 
Lung 8 (61.5) 5 (38.5)  
Other 22 (48.9) 23 (51.1)  
Non-applicable (non-oncological patient) 2 (66.7) 1 (33.3)  
Stage   0.888* 
Local or loco-regional disease 9 (56.2) 7 (43.5)  
Metastasic 21 (50) 21 (50)  
Non-applicable (non-oncological patient) 2 (66.7) 1 (33.3)  
Intake of neuroleptics    0.404 
No 21 (56.8) 16 (43.2)  
Yes 11 (45.8) 13 (54.2)  
Intake of sympathicomimetica   0.151 
No 20 (46.5) 23 (53.5)  
Yes 12 (66.7) 6 (33.3)  
Intake of corticosteroids   0.933 
No 14 (51.9) 13 (48.1)  
Yes 18 (52.9) 16 (47.1)  
Intake of diuretics   0.107 
No 18 (45) 22 (55)  
Yes 14 (66.7) 7 (33.3)  
Intake of opioids   0.963 
No 9 (52.9) 8 (47.1)  
Yes 23 (52.3) 21 (47.7)  
Intake of other psyhotropics    0.275 
No 22 (57.9) 16 (42.1)  
Yes 10 (43.5) 13 (56.5)  
Intake of benzodiazepines   0.972 
No 12 (52.2) 11 (47.8)  
Yes 20 (52.6) 18 (47.4)  
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* Statistical significance persisted after multivariate analysis 
Table 6 (continued). Relationship between the studied variables and moderate to severe 
insomnia according to the Sleep Disturbance Scale (n=61) 
Variables Moderate to severe insomnia P-value 
 n (%) n (%)  
 No Yes  
 32 (52.5) 29 (47.5)  
Other sleep factors    
Insomnia according to the single question   0.002 
No 18 (78.3) 5 (21.7)  
Yes 14 (36.8) 24 (63.2)  
Being moderately worried about insomnia   0.010 
No 14 (77.8) 4 (22.2)  
Yes 18 (41.9) 25 (58.1)  
Reported hours sleep per night   0.277 
<5 9 (42.9) 12 (57.1)  
≥5 23 (57.5) 17 (42.5)  
Feeling of non-restorative sleep    0.913 
No 15 (51.7) 14 (48.3)  
Yes 17 (53.1) 15 (46.9)  
Daytime somnolence    0.010* 
No 4 (25) 12 (75)  
Yes 28 (62.2) 17 (37.8)  
Physical factors    
Pain   0.986 
No 10 (52.6) 9 (47.4)  
Yes 22 (52.4) 20 (47.6)  
Dyspnea   0.436 
No 19 (58.7) 20 (51.3)  
Yes 13 (59.1) 9 (40.9)  
Cough    0.381 
No 21 (48.8) 22 (51.2)  
Yes 11 (61.1) 7 (38.9)  
Nausea, vomiting    0.501 
No 23 (50) 23 (50)  
Yes 9 (60) 6 (40)  
Sweating    0.910 
No 25 (52.1) 23 (47.9)  
Yes 7 (53.8) 6 (46.2)  
Nycturia    0.412 
No 25 (50) 25 (50)  
Yes 7 (63.6) 4 (36.4)  
Functional incontinence    0.881 
No 28 (52.8) 25 (47.2)  
Yes 4 (50) 4 (50)  
Itch    0.285 
No 27 (50) 27 (50)  
Yes 5 (71.4) 2 (28.6)  
Restless-legs   0.662 
No 30 (53.6) 26 (46.4)  
Yes 2 (40) 3 (60)  
Fever     0.475 
No 32 (53.3) 28 (46.7)  
Yes 0 (0) 1 (100)  
Drug or tobacco abstinence   1.000 
No 30 (51.7) 28 (48.3)  
Yes 2 (66.7) 1 (33.3)  
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* Statistical significance persisted after multivariate analysis 
 
 
 
Table 6 (continued). Relationship between the studied variables and moderate to severe 
insomnia according to the Sleep Disturbance Scale (n=61) 
Variables Moderate to severe insomnia P-value 
 n (%) n (%)  
 No Yes  
 32 (52.5) 29 (47.5)  
Psychological factors    
HADS score 20.25±7.79 23.07±7.44 0.158 
Clinically significant emotional distress  (HAD≥19)   0.806 
No 12 (54.5) 10 (45.5)  
Yes 20 (51.3) 19 (48.7)  
Subscala depression (HADD)   0.306 
HADD<11 14 (60.9) 9 (39.1)  
HADD≥11 18 (47.4) 20 (52.6)  
Subscala anxiety (HADA)    0,234 
HADA<11 17 (60.7) 11 (39.3)  
HADA≥11 15 (45.4) 18 (54.5)  
Nightmares    0.163 
No 26 (57.8) 19 (42.2)  
Yes 6 (37.5) 10 (62.5)  
Rumination   0.009* 
No 11 (86.4) 2 (15.4)  
Yes 21 (43.8) 27 (56.3)  
Fealings of fear or loneliness    0.055 
No 20 (64.5) 11 (35.5)  
Yes 12 (40) 18 (60)  
Clear knowledge on the current diagnosis    0.065 
No 17 (43.6) 22 (56.4)  
Yes 15 (68.2) 7 (31.8)  
Clear knowledge on the current prognosis    0.404 
No 5 (41.7) 7 (58.3)  
Yes 27 (55.1) 22 (44.9)  
Environmental factors (noise, light)    
Environmental disturbances   0.026 
No 11 (78.6) 3 (21.4)  
Yes 21 (44.7) 26 (55.3)  
Individual room    0.754 
No 22 (51.2) 21 (48.8)  
Yes 10 (55.6) 8 (44.4)  
Accompanied by a next of kin during night   0.204 
No 22 (47.8) 24 (52.2)  
Yes 10 (66.7) 5 (33.3)  
Sleep habits not accomplished at the PCU   0.276 
No 24 (57.1) 18 (42.9)  
Yes 8 (42.1) 11 (57.9)  
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Table 7. Relationship between clinically significant emotional distress and other sleep 
aspects (n=61) 
Sleep aspects Clinically significant emotional 
distress 
P-
value 
 n (%) n (%)  
 No Yes  
 22 (36.1) 39 (63.9)  
Being moderately worried about insomnia    0.040 
Yes (≥3) 12 (27.9) 31 (72.1)  
No (<3) 10 (55.6) 8 (44.4)  
Feeling of non-restorative sleep   0.175 
Yes 9 (28.1) 23 (71.9)  
No 13 (44.8) 16 (55.2)  
Daytime somnolence   0.889 
Yes 16 (35.6) 29 (64.4)  
No 6 (37.5) 10 (62.5)  
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Table 8. Relationship between rumination and other psychological factors (n=61) 
Psychological factors Nocturnal rumination P-
value 
 n (%) n (%)  
 No Yes  
 13 (21.3) 48 (78.7)  
Clinically significant emotional distress  (HADS≥19)   0.132 
No 7 (31.8) 15 (68.2)  
Yes 6 (15.4) 33 (5.6)  
Subscala depression (HADD)   0.059 
HADD<11 5 (13.5) 33 (86.8)  
HADD≥11 8 (34.8) 15 (65.2)  
Subscala anxiety (HADA)    0.010 
HADA<11 10 (35.7)  18 (64.3)  
HADA≥11 3 (9.1) 30 (90.9)  
Nightmares    0.771 
No 10 (22.2) 35 (77.8)  
Yes 3 (18.8) 13 (81.3)  
Fealings of fear or loneliness    0.134 
No 9 (29) 22 (71)  
Yes 4 (13.3) 26 (86.7)  
Clear knowledge on the current diagnosis    0.050 
No  8 (36.4) 14 (63.6)  
Yes 5 (12.8) 34 (87.2)  
Clear knowledge on the current prognosis    0.221 
No 12 (24.5) 37 (75.5)  
Yes 1 (8.3) 11 (91.7)  
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Table 9. Relationship between rumination and insomnia items (n=61) 
Insomnia items Nocturnal rumination P-
value 
 n (%) n (%)  
 No Yes  
 13 (21.3)  48 (78.7)  
Difficulty in falling asleep (Likert 0-10)   0.517 
No (<5) 7 (53.8) 6 (46.2)  
Yes (≥5) 21 (43.8) 27 (56.3)  
Waking up during the night (Likert 0-10)   0.011 
No (<5) 9 (69.2) 4 (30.8)  
Yes (≥5) 14 (29.2) 34 (70.8)  
Waking up too early in the morning (Likert 0-10)   0.004 
No (<5) 11 (84.6) 2 (15.4)  
Yes (≥5) 19 (39.6) 29 (60.4)  
Reported hours sleep per night   0.332 
<5 3 (14.3) 18 (85.7)  
≥5 10 (25) 30 (75)  
Being moderately worried about insomnia (Likert 0-5)   0.043 
No (<3) 7 (38.9) 11 (61.1)  
Yes (≥3) 6 (14) 37 (86)  
 
 
 
 
 
 
 
 
 
 
 
 
 
Insomnia in hospitalised patients with advanced disease 
Renom Guiteras A  
  
 
 38
 
* Statistical analysis excluded the 3d group 
 
 
 
Table 10. Relationship between the sociodemographical and clinical characteristics and 
daytime somnolence (n=61) 
Variables Daytime somnolence  P-value 
 n (%) n (%)  
 No Yes  
 16 () 45 ()  
Sociodemographical and clinical characteristics    
Age  72.8 ± 10.78 70.87 ± 11.10 0.546 
Sex   0.962 
Women 7 (25.9) 20 (74.1)  
Men 9 (26.5) 25 (73.5)  
Karnofsky index    0.097 
>50 7 (43.8) 9 (56.3)  
≤50 9 (20) 36 (80)  
Procedence (home vs acute care)   0.310 
Home 8 (33.3) 16 (66.7)  
Acute Care 8 (21.6) 29 (78.4)  
Death during hospitalisation in the PCU   0.171 
No 11 (33.3) 22 (66.7)  
Yes 5 (17.9) 23 (82.1)  
Cancer site   0.743* 
Lung 3 (23.1) 10 (76.9)   
Other 13 (28.9) 32 (71.1)  
Non-applicable (non-oncological patient) 0 3 (100)  
Stage   1.000* 
Local or loco-regional disease 4 (25) 12 (75)  
Metastasic 12 (28.6) 30 (71.4)  
Non-applicable (non-oncological patient) 0 3 (100)  
Intake of neuroleptics    0.310 
No 8 (21.6) 29 (78.4)  
Yes 8 (33.3) 16 (66.7)  
Intake of sympathicomimetica   0.757 
No 12 (27.9) 31 (72.1)  
Yes 4 (22.2) 14 (77.8)  
Intake of corticosteroids   0.962 
No 7 (25.9) 20 (74.1)  
Yes 9 (26.5) 25 (73.5)  
Intake of diuretics   0.124 
No 13 (32.5) 27 (67.5)  
Yes 3 (14.3) 18 (85.7)  
Intake of opioids   0.116 
No 7 (41.2) 10 (58.8)   
Yes 9 (20.5) 35 (79.5)  
Other psychotropic (antidepressant, anticonvulsivant)   0.015 
No 14 (36.8) 24 (63.3)  
Yes 2 (8.7) 21 (91.3)  
Intake of benzodiazepines   0.075 
No 9 (39.1) 14 (60.9)  
Yes 7 (18.4) 31 (81.6)  
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Figure 1. Judged main factor interfering with sleep quality 
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Annex 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Annex 2 is written in the language that was used in the study (Catalan for the Case 
Report Form and Spanish for some of the instruments used). 
 
Annex 2 includes: 
- The Case Report Form 
- The evaluation instruments  
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CASE REPORT FORM 
 
FIRST PART 
Data collected by means of an interview with the patient (the blank box 
contains a number assigned to each patient)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Insomnia in hospitalised patients with advanced disease 
Renom Guiteras A  
  
 
 42
INSOMNI EN PACIENTS HOSPITALITZATS AMB MALALTIA AVANÇADA: 
PREVALENÇA I FACTORS RELACIONATS. 
                                                                            
 
 
- Dia de l’exploració: 
 
- NHC (eliminat posteriorment) 
 
- Í. Karnofsky ingrés: 
 
- Í. Pfeiffer: 
 
- Mobilitat: 
1- Enllitat 100% 
2- Sedestació/cadira de rodes 
3- Deambulació: autònoma/supervisada/ajuda 
 
- Té problemes per dormir a la nit des que ha ingressat a la Unitat? 
1- Sí 
0- No 
2- A vegades 
 
- Ha tingut dificultats per a dormir... 
1- abans del diagnòstic de la malaltia actual?  1- Sí   / 0- No 
2- des del diagnòstic de la malaltia actual?  1- Sí   / 0- No 
3- des de l’ingrés a UCP?    1- Sí   / 0- No 
 
- Li preocupa el fet de dormir malament? (0-5) 
 
- S’adorm durant el dia? (somnolència diürna) 
1- Sí 
0- No 
- Té la sensació de no haver descansat al matí quan es desperta? (sensació de son 
no reparador) 
1- Sí 
0- No 
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QÜESTIONARI DE L’INSOMNI: 
Sleep disturbance scale 
Durant els dies que porta ingressat...  
(i tenint en compte que “0” significa gens i “10” molt) 
 
a. Ha tingut dificultat per adormir-se? (0-10) 
b. S’ha despertat durant la nit? (0-10) 
c. S’ha despertat massa d’hora al matí? (0-10) 
Hores totals de son/nit: 
1- <5 
2- =o>5 
OVERALL SLEEP DISTURBANCE SCORE (a+b+c/3): 
 
FACTORS FÍSICS QUE INTERFEREIXEN AMB EL SON (poden ser més d’un) 
- Sudoració   1- Sí  / 0- No 
- Dispnea   1- Sí  / 0- No 
- Dolor    1- Sí  / 0- No 
- Nictúria   1- Sí  / 0- No 
- Incontinència funcional 1- Sí  / 0- No 
- Pruïja    1- Sí  / 0- No 
- Tos    1- Sí  / 0- No 
- Nàusees, vòmits  1- Sí  / 0- No 
- Febre    1- Sí  / 0- No 
- Sdme cames inquietes 1- Sí  / 0- No 
- Abstinència tabac/drogues 1- Sí  / 0- No 
- Altres:    1- Sí   / 0- No 
 
FACTORS AMBIENTALS: 
- Li molesta alguna cosa de l’ambient per dormir? 
1- Excés de llum/soroll pel company d’habitació 1- Sí   / 0- No 
2- Excés de llum/sorolls a la planta en general  1- Sí   / 0- No 
3- Interrupcions      1- Sí   / 0- No 
4- Altres (discomfort tèrmic...)    1- Sí   / 0- No 
 
- Dorm acompanyat de familiars?  1- Sí   / 0- No 
- Està en una habitació individual? 1- Sí   / 0- No 
- Hàbits previs abans d’anar a dormir que no pot realitzar a la UCP: 
1- Sí. Quins (televisió, llet, lectura, ràdio, diferent horari...)?: 
0- No 
 
FACTORS PSICOLÒGICS: 
- HAD: 
- Malsons:    1- Sí / 0-  No 
- Rumiacions durant la nit:    
1-Sí  / 0-  No 
- Pensaments de mort 
- Preocupacions familiars-laborals 
- Altres (records,...) 
      -     Sentiment de por o soletat?   1- Sí  / 0- No 
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- A partir de l’interrogatori fet fins ara, l’entrevistador dedueix el grau 
d’informació que té el pacient sobre la seva malaltia: 
- Diagnòstic: 
1- Clarament el coneix  
2- No queda clar 
3- Clarament no el coneix 
            - Pronòstic: 
1- Clarament el coneix  
2- No queda clar 
3- Clarament no el coneix 
De tot el que hem dit fins ara, què és el que creu que més li interfereix amb el son? 
1- Símptoma físic: 
2- Factor ambiental: 
3- Símptoma psicològic: 
4- Altres: 
5- No ho sé. 
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CASE REPORT FORM 
 
SECOND PART 
Data collected by reading the patients’ medical reports 
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- Num. recollida: 
- Data d’ingrés: 
- Sexe: 
1- Home 
2- Dona 
- Edat: 
- Procedència:  
1- Domicili 
 PADES 
 No PADES 
2- Hospital d’aguts 
3-   Altres 
- Malaltia oncològica:  
1- Sí 
0- No 
       -    Tumor primari: 
1- Pulmó 
2- Mama 
3- Colon 
4- Fetge 
5- Pàncrees 
6- Estómac 
7- Cerebral 
8- Pròstata 
9- Hematològic 
10- Ginecològic 
11- Altres: 
12- Desconegut 
 
         -    Extensió tumoral: 
1- Local 
2- Regional 
3- Disseminat 
4- Desconegut 
 
          -    Afectació SNC (metàstasi, primari o paraneoplàsic): 
1- Sí 
2- No 
3- No se sap 
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            -    Altres diagnòstics:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- Fàrmacs i altres substàncies de base (no inclou intervencions específiques per a 
l’insomni durant l’ingrés): 
 
Fàrmac Sí No 
Quimioteràpia   
Estimulants SNC (cafè, anfetamines)   
Neurolèptics per nàusees i vòmits (metoclopramida, 
haloperidol, ondansetron) 
  
Simpaticomimètics   
Corticoides   
Diürètics   
Opioides   
Antihistamínics   
Benzodiazepines   
Altres psicotròpics (antidepressius, anticonvulsivants)  
Altres   
Abstinència enol/tabac   
 
- Supressió de psicòtrops recent (opioides, sedants antihistamínics, 
benzodiazepines, antidepressius tricíclics, inhibidors de la monoaminooxidasa) 
1- Sí 
0- No 
- Abstinència enol/tabac: 
1- Sí 
0- No 
- Nombre de fàrmacs:  
- Destí a l’alta: defunció / domicili / unitat de llarga estada / altres 
 
 
 
 
Altres diagnòstics Sí No 
Demència coneguda   
Trastorn psicòtic   
Depressió   
Ansietat   
Trastorn de personalitat   
Malaltia cerebrovascular   
Cardiopatia   
Hepatopatia crònica   
Pneumopatia crònica   
Insuficiència renal crònica   
Trastorn hidroelectrolític   
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EVALUATION INSTRUMENTS 
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ESCALA DE ANSIEDAD Y DEPRESIÓN HOSPITALARIA (HADS)  
(Zigmond and Snaith,  1983) 
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QÜESTIONARI D’INSOMNI (Sleep disturbance scale)  
Anderson et al. 2003 
 
 
 
Qüestionari d’Insomni (Sleep Disturbance Scale) 
Anderson et al 2003 
 
Durant els dies que porta ingressat 
(i tenint en compte que “0” significa gens i “10” molt): 
 
a. Ha tingut dificultat per adormir-se? (0-10) 
b. S’ha despertat durant la nit? (0-10) 
c. S’ha despertat massa d’hora al matí? (0-10) 
 
Hores totals de son/nit: 
<5 
=o>5 
 
OVERALL SLEEP DISTURBANCE SCORE (a+b+c/3): 
 
CUESTIONARIO CORTO DEL ESTADO MENTAL DE PFEIFFER  
Short Portable Mental Status Questionnaire (SPMSQ)  (Pfeiffer, 1975) 
 
Acierto  Error 
1. ¿Cuál es la fecha de hoy? (mes, día y año)        □        □ 
2. ¿Qué día de la semana es hoy?              □      □ 
3. ¿Cuál es el nombre de este lugar?            □      □ 
4. ¿Cuál es su número de teléfono?             □      □ 
    ¿Cuál es su dirección? (si no tiene teléfono)           □      □ 
5. ¿Qué edad tiene usted?               □      □ 
6. ¿Cuál es la fecha de su nacimiento?          □      □ 
7. ¿Quién es ahora el presidente del gobierno?            □      □ 
8. ¿Quién fue el anterior presidente del gobierno?           □      □ 
9. ¿Cuáles son los dos apellidos de su madre?           □      □ 
10. Vaya restando de 3 en 3 a partir de 20 hasta llegar a 0         □      □ 
 
Número total de errores: _______ 
 
0-2 errores: normal. 
3-4 errores: deterioro mental leve 
5-7 errores: deterioro mental moderado. 
8-10 errores: deterioro mental severo 
Con baja escolarización se permite un error más. 
Con estudios superiores se contabiliza con un error menos. 
 
 
 
ÍNDICE DE KARNOFSKY (Karnofsky et al, 1949) 
100 Actividad normal. Sin síntomas. Sin evidencia subjetiva de enfermedad 
90 Capaz de desarrollar su actividad normal. Síntomas mínimos de enfermedad 
80 Actividad normal con esfuerzo. Algunos síntomas subjetivos de enfermedad 
70 Puede cuidar de sí mismo. Incapaz de desarrollar su actividad normal o de hacer su trabajo 
60 Requiere asistencia ocasional, pero capaz de cuidar de sí mismo 
50 Requiere asistencia considerable y frecuente atención médica 
40 Requiere asistencia médica especial 
30 Gravemente inhábil. Necesita hospitalización, si bien no se prevé una muerte inminente 
20 Muy enfermo. Hospitalización necesaria. Es preciso un tratamiento de soporte activo 
10 Moribundo 
0 Muerto 
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